MarketMindUS Markets Closed
AI-assisted · Not financial adviceNot adviceAI-assisted · Not financial advice.
Recursion and Summit's drug discovery strategies
Target: $6 avg
4 Buy · 6 Hold · 0 Sell
Based on curated news sources (not retail comments)
Over the last 7 days: Insufficient information to form a clear view on RXRX, resulting in a neutral stance.